Cytochrome P450 3A1 (CYP3A1)
CYPIIIA1; Cytochrome P450-PCN1
Thymoquinone protected against renal I/R-induced damage through an antioxidant mechanism as well as the decrease of CYP3A1 and SSAT gene expression.
Thymoquinone treatment caused the reversal of I/R-induced changes in MDA as well as GST and SOD activity. Moreover, I/R caused a significant rise in creatinine and alanine aminotransferase serum levels. CYP3A1 mRNA expression was induced significantly by I/R in both liver and kidney tissues compared with sham group. Thymoquinone reduced significantly this increase. I/R caused induction of mRNA expression of spermidine/spermine N-1-acetyl-transferase (SSAT), a catabolic enzyme that participates in polyamine metabolism, in liver and kidney tissues. Thymoquinone reduced SSAT mRNA expression significantly in liver and markedly in kidney.
Organism species: Rattus norvegicus (Rat)
- Customized Service n/a Recombinant Cytochrome P450 3A1 (CYP3A1) Recombinant Protein Customized Service Offer
- Customized Service n/a Monoclonal Antibody to Cytochrome P450 3A1 (CYP3A1) Monoclonal Antibody Customized Service Offer
- Customized Service n/a Polyclonal Antibody to Cytochrome P450 3A1 (CYP3A1) Polyclonal Antibody Customized Service Offer
- Sandwich ELISA SEB150Ra ELISA Kit for Cytochrome P450 3A1 (CYP3A1) In Stock